KUP-101

N/A

Report date: 2022/11/02 11:41:41
NME

Base Information

Drug NameKUP-101
Drug Alias NameKUP-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 agonistsToll like receptor 7 agonists
TargetsToll like receptor 4Toll like receptor 7
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKupando GmbH
China Registration ClassN/A

Develop Information

Active CompaniesKupando GmbH
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A